Twelve-months treatment with dapagliflozin improves endothelial glycocalyx and cardiovascular function in patients with type 1 diabetes mellitus

被引:0
|
作者
Ikonomidis, I. [1 ]
Katogiannis, K. [2 ]
Kountouri, A. [3 ]
Pavlidis, G. [2 ]
Thymis, J. [2 ]
Korakas, E. [2 ]
Kostelli, G. [2 ]
Katsanaki, E. [2 ]
Michalopoulou, E. [2 ]
Vlachomitros, D. [2 ]
Pliouta, L. [3 ]
Balampanis, K. [3 ]
Lambadiari, V [3 ]
机构
[1] Natl & Kapodistrian Univ Athens, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Cardiol Dept 2, Athens, Greece
[3] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Res Unit & Diabet Ctr, Dept Internal Med 2, Athens, Greece
关键词
D O I
10.1093/eurheartj/ehae666.2924
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Four-months treatment with dapagliflozin improves endothelial glycocalyx and cardiovascular function in patients with type 1 diabetes mellitus
    Ikonomidis, I.
    Kountouri, A.
    Pavlidis, G.
    Katogiannis, K.
    Thymis, J.
    Pliouta, L.
    Korakas, E.
    Balampanis, K.
    Bamias, A.
    Lambadiari, V.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2687 - 2687
  • [2] Dapagliflozin improves arterial stiffness, myocardial performance and endothelial glycocalyx in patients with type 1 diabetes after four months treatment
    Lambadiari, V.
    Kountouri, A.
    Katogiannis, K.
    Pavlidis, G.
    Korakas, E.
    Pliouta, L.
    Kostelli, G.
    Balampanis, K.
    Thymis, J.
    Raptis, A.
    Ikonomidis, I.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S285 - S285
  • [3] Four months treatment with dapagliflozin or dulaglutide improves cardiovascular function in patients with type 2 diabetes and ischaemic stroke
    Kountouri, A.
    Ikonomidis, I.
    Prentza, V.
    Katogiannis, K.
    Pavlidis, G.
    Korakas, E.
    Pliouta, L.
    Kostelli, G.
    Michalopoulou, E.
    Thymis, J.
    Balampanis, K.
    Raptis, A.
    Tsivgoulis, G.
    Lambadiari, V.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S418 - S418
  • [4] Dapagliflozin Improves Endothelial Function and Microvascular Reactivity in Type 2 Diabetes Mellitus
    Korzh, Oleksii
    Titkova, Anna
    Krasnokutskiy, Sergiy
    AMERICAN HEART JOURNAL, 2020, 229 : 168 - 168
  • [5] Dapagliflozin for the treatment of type 1 diabetes mellitus
    Pafili, Kalliopi
    Maltezos, Efstratios
    Papanas, Nikolaos
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (07) : 873 - 881
  • [6] Dapagliflozin treatment for type 2 diabetes mellitus patients with a history of cardiovascular disease
    Leiter, L.
    Cefalu, W.
    DeBruin, T.
    Gause-Nilsson, I.
    Sugg, J.
    Parikh, S.
    DIABETOLOGIA, 2012, 55 : S310 - S311
  • [7] Six months pump treatment improves cardiovascular and endothelial function compared to MDI in patients with type 1 diabetes, independently of HbA1c
    Kountouri, A.
    Ikonomidis, I.
    Thymis, J.
    Korakas, E.
    Katogiannis, K.
    Prentza, V.
    Balampanis, K.
    Pliouta, L.
    Kousathana, F.
    Kostelli, G.
    Benas, D.
    Barmpagianni, A.
    Dimitriadis, G.
    Liatis, S.
    Lambadiari, V.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 296 - 296
  • [8] Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease
    Hong, Ju-Young
    Park, Keun-Young
    Kim, Jong-Dai
    Hwang, Won-Min
    Lim, Dong-Mee
    JOURNAL OF OBESITY & METABOLIC SYNDROME, 2020, 29 (03) : 215 - 221
  • [9] Dapagliflozin Treatment for Type 2 Diabetes Mellitus Patients With Comorbid Cardiovascular Disease and Hypertension
    Cefalu, William T.
    Leiter, Lawrence A.
    Debruin, Tjerk W.
    Gausenilsson, Ingrid
    Sugg, Jennifer
    Parikh, Shamik J.
    DIABETES, 2012, 61 : A271 - A271
  • [10] DAPAGLIFLOZIN IMPROVES ARTERIAL STIFFNESS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Fernandez-Alonso, Camilo
    Roffidal, Louise
    Sander, Gary
    Giles, Thomas
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 2022 - 2022